News — University of Oxford, Medical Sciences Division

A person holds a mobile phone displaying the NHS COVID-19 app

NHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds

22 February 2023

A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.

Healthcare worker conducting a COVID test at the Hospital for Tropical Diseases in Bangkok

Study supports evidence ivermectin not effective to treat COVID-19

21 February 2023

High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.

Coronavirus Vaccines Research and Development Roadmap launched

21 February 2023

The Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.

COVID-19 is a leading cause of death in children and young people in the US

31 January 2023

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

COVID-19 increased public trust in science, new survey shows

26 January 2023

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

17 January 2023

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.

Research at the Outbreak of a Pandemic – thanking our donors

12 December 2022

A 35-page full-colour report was sent out to hundreds of donors as a thank you for their important contributions, and to show them the difference they helped to make during the pandemic.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

28 October 2022

Researchers from Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

Ariel view of a sparse crowd in an urban environment

COVID-19 continued to hit life expectancy in 2021 in unvaccinated populations and Eastern Europe

17 October 2022

COVID-19 has caused a protracted shock to life expectancy levels, leading to global mortality changes unprecedented in the last 70 years, according to research published in Nature Human Behaviour from Oxford’s Leverhulme Centre for Demographic Science and the Max Planck Institute for Demographic Research.

Gene associated with better immune response, protection after COVID-19 vaccination

13 October 2022

Researchers from the University of Oxford have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines – identifying a particular gene associated with a high antibody response.

3D illustration of human body lung anatomy

New computational technique reveals changes to lung function post COVID-19 infection

5 October 2022

A new study led by Oxford researchers found that prior COVID-19 infection was associated with more uneven inflation of the lungs during normal breathing, smaller lung volumes, and greater respiratory dead space.

A vial of the Oxford-AstraZeneca vaccine

Oxford vaccine saved most lives in its first year of rollout

15 July 2022

When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.

Artists impression of a mutating coronavirus

Novel all-in-one vaccine developed to tackle future coronavirus threats

6 July 2022

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Patient being given a vaccination by a healthcare professional

COVID-19 vaccine protects people of all body weights from hospitalisation and death, a study of 9 million adults in England finds

1 July 2022

Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

29 June 2022

The Oxford Clinical Trials Research Unit at Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) played a key role in the Vaccine Response On Off Methotrexate (VROOM) study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Five ways the pandemic has affected routine medical care

24 June 2022

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

A doctor holding a COVID-19 vaccine and another doctor examining a medical record.

Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

9 June 2022

People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study published in The Lancet Rheumatology with the involvement of researchers from the University of Oxford.

Search results (372)